Managing Director and CEO, Dr Malcolm Parmenter says they have seen a strong increase in demand and are now undertaking around 2,500 COVID-19 tests per day at their laboratories.
Countering this, certain non-critical and routine services have declined in step with community concerns around visiting healthcare centres. We are also experiencing increased consumable costs.
Shares in Healius (ASX:HLS) are trading 2.67 per cent lower at $2.19.